The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod
Open accessAbstract
BACKGROUND: Alternatives to surgery are needed for the treatment of vulvar intraepithelial neoplasia. We investigated the effectiveness of imiquimod 5% cream, a topical immune-response modulator, for the treatment of this condition. METHODS: Fifty-two patients with grade 2 or 3 vulvar intraepithelial neoplasia were randomly assigned to receive either imiquimod or placebo, applied twice weekly for 16 weeks. The primary outcome was a reduction of more than 25% in lesion size at 20 weeks. Secondary outcomes were histologic regression, clearance of human papillomavirus (HPV) from the lesion, changes in immune cells in the epidermis and dermis of the vulva, relief of symptoms, improvement of quality of life, and durability of response. Reduction in lesion size was classified as complete response (elimination), strong partial response (76 to 99% reduction), weak partial response (26 to 75% reduction), or no response (< or =25% reduction). The follow-up period was 12 months. RESULTS: Lesion size was reduced by more than 25% at 20 weeks in 21 of the 26 patients (81%) treated with imiquimod and in none of those treated with placebo (P<0.001). Histologic regression was significantly greater in the imiquimod group than in the placebo group (P<0.001). At baseline, 50 patients (96%) tested positive for HPV DNA. HPV cleared from the lesion in 15 patients in the imiquimod group (58%), as compared with 2 in the placebo group (8%) (P<0.001). The number of immune epidermal cells increased significantly and the number of immune dermal cells decreased significantly with imiquimod as compared with placebo. Imiquimod reduced pruritus and pain at 20 weeks (P=0.008 and P=0.004, respectively) and at 12 months (P=0.04 and P=0.02, respectively). The lesion progressed to invasion (to a depth of <1 mm) in 3 of 49 patients (6%) followed for 12 months (2 in the placebo group and 1 in the imiquimod group). Nine patients, all treated with imiquimod, had a complete response at 20 weeks and remained free from disease at 12 months. CONCLUSIONS: Imiquimod is effective in the treatment of vulvar intraepithelial neoplasia. (Current Controlled Trials number, ISRCTN11290871 [controlled-trials.com].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Self-citationSF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Aaronson, N. K., Muller, M., Cohen, P. D. A., Essink-Bot, M.-L., Fekkes, M., Sanderman, R., Sprangers, M. A. G., te Velde, A., & Verrips, E. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00097-3 · Cited by 2,276
Self-citationSprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220
van den Brule, A. J. C., Pol, R., Fransen-Daalmeijer, N., Schouls, L. M., Meijer, C. J. L. M., & Snijders, P. J. F. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.779-787.2002 · Cited by 553
Self-citationSideri, M., Jones, R. W., Wilkinson, E. J., Preti, M., Heller, D. S., Scurry, J., Haefner, H., & Neill, S. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000201921.69949.10 · Cited by 339
van Seters, M., van Beurden, M., & de Craen, A. J. M. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.02.012 · Cited by 338
Self-citationVulvar Intraepithelial Neoplasia: Aspects of the Natural History and Outcome in 405 Women
Jones, R. W., Rowan, D. M., & Stewart, A. W. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187301.76283.7f · Cited by 273
Mechanisms Used by Human Papillomaviruses to Escape the Host Immune Response
Kanodia, S., Fahey, L., & Kast, W. M. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006869 · Cited by 241
Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts
Beutner, K. R., Tyring, S. K., Trofatter, K. F., Douglas, J. M., Spruance, S., Owens, M. L., Fox, T. L., Hougham, A. J., & Schmitt, K. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.789 · Cited by 225
Cited by
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Lowik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Essahsah, F., Fathers, L. M., Offringa, R., Drijfhout, J. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810097 · Cited by 1,102
Dougan, M., & Dranoff, G. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132544 · Cited by 607
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Melero, I., Castanon, E., Alvarez, M., Champiat, S., & Marabelle, A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00507-y · Cited by 493
Cancer immunotherapy – revisited
Lesterhuis, W. J., Haanen, J. B. A. G., & Punt, C. J. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3500 · Cited by 427
Human Papillomavirus Type-Distribution in Vulvar and Vaginal Cancers and Their Associated Precursors
Smith, J. S., Backes, D. M., Hoots, B. E., Kurman, R. J., & Pimenta, J. M. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31819bd6e0 · Cited by 273
Metadata
- Authors
- van Seters, M., van Beurden, M., ten Kate, F. J. W., Beckmann, I., Ewing, P. C., Eijkemans, M. J. C., Kagie, M. J., Meijer, C. J. M., Aaronson, N. K., KleinJan, A., Heijmans-Antonissen, C., Zijlstra, F. J., Burger, M. P. M., & Helmerhorst, T. J. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-04-03
- Volume
- 358
- Issue
- 14
- Pages
- 1465-1473
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2097648465
- Cited by
- 398
- References
- 21
- FWCI
- 30.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod. https://app.cochat.ai/papers/10.1056/nejmoa072685
- The paper
- van Seters, M., van Beurden, M., ten Kate, F. J. W., Beckmann, I., Ewing, P. C., Eijkemans, M. J. C., Kagie, M. J., Meijer, C. J. M., Aaronson, N. K., KleinJan, A., Heijmans-Antonissen, C., Zijlstra, F. J., Burger, M. P. M., & Helmerhorst, T. J. M. (2008). Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod. New England Journal of Medicine. https://doi.org/10.1056/nejmoa072685
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.